We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Tap Coffee have been trading for the last 5 years and have been profitable for the last 3. They roast, retail, wholesale and sell their coffee online. Currently Tap Coffee have 3 busy coffee stores located in central London. 
days to go: Expired investment: £86,510
Perfect World Ice Cream is a healthy indulgent treat which is good for you. They have less sugar, less calories and real fruit and vegetable purees which provide health benefits. They have created a range of family friendly flavours and are available in stores such as Holland & Barratt, Tescos and Ocado. 
days to go: Expired investment: £147,360
Sunswap is a solar and battery-powered transport refrigeration company that keeps food, medicine, and vaccines cold whilst on the road. The company argues that diesel-powered Transport Refrigeration Units (TRUs) are expensive to operate and highly polluting. It proclaims that replacing a diesel TRU with a Sunswap TRU could be the equivalent of removing 31 cars from the road. Sunswap asserts that the TRU market would have a market worth £13.4 billion by 2030. The company aims to be a contender in this segment and claims that electric TRU sales will follow the electric vehicle adoption curve with a 60% Year-on-Year growth. Sunswap has successfully tested its working prototype's capability to meet the temperature requirements of -22°C. It is collaborating with six major UK supermarkets on product development, with aims to secure sales with them in 2021. The company will use the investment to grow its team, build the next generation product, and secure sales by the end of 2021.
days to go: Expired investment: £535,000
Pact Coffee is an online seller of roasted coffee beans. All of Pact Coffee's beans are shipped within 7 days of roasting as this is when they taste the best. With the money invested, Pact look to develop new products and expand into 2 new european countries.      
days to go: Expired investment: £195,400
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph